M
Masatsugu Hori
Researcher at National University of Ireland, Galway
Publications - 2
Citations - 1710
Masatsugu Hori is an academic researcher from National University of Ireland, Galway. The author has contributed to research in topics: Aspirin & Rivaroxaban. The author has an hindex of 2, co-authored 2 publications receiving 1283 citations.
Papers
More filters
Journal ArticleDOI
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom,Stuart J. Connolly,Jackie Bosch,Gilles R. Dagenais,Robert G. Hart,Olga Shestakovska,Rafael Diaz,Marco Alings,Eva Lonn,Sonia S. Anand,Petr Widimsky,Masatsugu Hori,Alvaro Avezum,Leopoldo S. Piegas,Kelley R. Branch,Jeffrey L. Probstfield,Deepak L. Bhatt,Jun Zhu,Yan Liang,Aldo P. Maggioni,Patricio Lopez-Jaramillo,Martin O'Donnell,Ajay K. Kakkar,Keith A.A. Fox,Alexander Parkhomenko,Georg Ertl,Stefan Störk,Matyas Keltai,Lars Rydén,Nana Pogosova,Antonio L. Dans,Fernando Lanas,Patrick J. Commerford,Christian Torp-Pedersen,Tomek J. Guzik,Peter Verhamme,Dragos Vinereanu,Jae-Hyung Kim,Andrew Tonkin,Basil S. Lewis,Camilo Felix,Khalid Yusoff,P. Gabriel Steg,Kaj Metsärinne,Nancy Cook Bruns,Frank Misselwitz,Edmond Chen,Darryl P. Leong,Salim Yusuf +48 more
TL;DR: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assign to aspirin alone.
Journal ArticleDOI
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
Jackie Bosch,Jackie Bosch,John W. Eikelboom,Stuart J. Connolly,Nancy Cook Bruns,Vivian Lanius,Fei Yuan,Frank Misselwitz,Edmond Chen,Rafael Diaz,Marco Alings,Eva Lonn,Petr Widimsky,Masatsugu Hori,Alvaro Avezum,Leopoldo S. Piegas,Deepak L. Bhatt,Kelley R. Branch,Jeffrey L. Probstfield,Yan Liang,Lisheng Liu,Jun Zhu,Aldo P. Maggioni,Patricio Lopez-Jaramillo,Martin O'Donnell,Keith A.A. Fox,Ajay K. Kakkar,Alexander Parkhomenko,Georg Ertl,Stefan Störk,Katalin Keltai,Matyas Keltai,Lars Rydén,Gilles R. Dagenais,Nana Pogosova,Antonio L. Dans,Fernando Lanas,Patrick J. Commerford,Christian Torp-Pedersen,Tomasz J. Guzik,Tomasz J. Guzik,Peter Verhamme,Dragos Vinereanu,Jae Hyung Kim,Jong-Won Ha,Andrew Tonkin,John Varigos,Basil S. Lewis,Camilo Felix,Khalid Yusoff,Philippe Gabriel Steg,Victor Aboyans,Kaj Metsärinne,Sonia S. Anand,Robert G. Hart,Andre Lamy,Paul Moayyedi,Darryl P. Leong,Mukul Sharma,Salim Yusuf +59 more
TL;DR: A double-blind superiority trial comparing rivaroxaban alone or in combination with aspirin, in the long-term management of patients with stable CAD or PAD, and on the efficacy and safety of pantoprazole in preventing upper GI complications in patients receiving antithrombotic therapy.